We have already seen the first wave of AI-powered dangers. Deepfakes, bot accounts, and algorithmic manipulation on social ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Each year, Phesi releases an analysis of the world’s most studied diseases. The survey includes data from the 67,569 ...

The grants have been the source of new treatments for cancer, heart disease, diabetes, strokes and H.I.V.; wonder drugs like ...

The scheme aims to deliver affordable generic drugs, which can be 50-80% cheaper than branded varieties, but has been hobbled ...

Adding fluorine to drug molecules can be tricky, but is often worthwhile. Rachel Brazil talks to the chemists trying to tame ...

Germany has very big problems. This is reported by the specialists of the statistical office Destatis, who published the ...

Keeping a lid on drug prices is proving costly for ambitions to turn the UK into a life sciences superpower ...

The Wuhan company didn’t bother with the dark web. It spruiked its goods right in the open, showing mounds of white powder ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

Cell line development plays a pivotal role in the manufacturing of therapeutic proteins, vaccines and other biologics.

Daniels says the shortage of brand name drugs like glucagon-like peptide-1 (GLP-1) medications to treat diabetes and obesity ...